Defence Therapeutics Statistics

Total Valuation

FRA:DTC has a market cap or net worth of EUR 28.38 million. The enterprise value is 28.78 million.

Market Cap	28.38M
Enterprise Value	28.78M

Important Dates

The last earnings date was Wednesday, November 19, 2025.

Earnings Date	Nov 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	54.73M
Shares Outstanding	n/a
Shares Change (YoY)	+15.72%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	4.15%
Owned by Institutions (%)	n/a
Float	52.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-32.95
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.00
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.12

Financial Position

The company has a current ratio of 0.93

Current Ratio	0.93
Quick Ratio	0.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.70
Interest Coverage	-14.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-129.42%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-59,150.41%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+23.06%
50-Day Moving Average	0.49
200-Day Moving Average	0.53
Relative Strength Index (RSI)	56.00
Average Volume (20 Days)	5,738

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.02M
Pretax Income	-2.21M
Net Income	-2.21M
EBITDA	-2.00M
EBIT	-2.02M
Earnings Per Share (EPS)	-0.04

Full Income Statement

Balance Sheet

The company has 1.42 million in cash and 1.82 million in debt, giving a net cash position of -397,579.

Cash & Cash Equivalents	1.42M
Total Debt	1.82M
Net Cash	-397,579
Net Cash Per Share	n/a
Equity (Book Value)	-861,155
Book Value Per Share	-0.02
Working Capital	-114,389

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.58 million and capital expenditures -12,920, giving a free cash flow of -2.59 million.

Operating Cash Flow	-2.58M
Capital Expenditures	-12,920
Free Cash Flow	-2.59M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:DTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.72%
Shareholder Yield	-15.72%
Earnings Yield	-7.80%
FCF Yield	-9.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1